Comera Life Sciences Holdings, Inc. (CMRA)
USD 0.0
(-50.0%)
USD 0.0
(-50.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2022 | 422.71 Thousand USD | 166.15% |
| 2021 | 158.82 Thousand USD | -53.08% |
| 2020 | 338.51 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 Q1 | 276.39 Thousand USD | 161.34% |
| 2023 Q3 | 94.34 Thousand USD | -63.57% |
| 2023 Q2 | 259.01 Thousand USD | -6.29% |
| 2022 Q3 | 173.95 Thousand USD | 88.71% |
| 2022 Q2 | 92.18 Thousand USD | 81.43% |
| 2022 Q1 | 50.81 Thousand USD | 47.71% |
| 2022 FY | 422.71 Thousand USD | 166.15% |
| 2022 Q4 | 105.76 Thousand USD | -39.2% |
| 2021 Q4 | 34.39 Thousand USD | -12.7% |
| 2021 Q3 | 39.4 Thousand USD | 195.15% |
| 2021 Q2 | 13.35 Thousand USD | -81.37% |
| 2021 Q1 | 71.67 Thousand USD | 0.0% |
| 2021 FY | 158.82 Thousand USD | -53.08% |
| 2020 FY | 338.51 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| America Great Health | 168.58 Thousand USD | -150.737% |
| Ampio Pharmaceuticals, Inc. | -250 Thousand USD | 269.085% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 176.717% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 337.479% |
| Better Therapeutics, Inc. | -2.72 Million USD | 115.49% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 130.521% |
| Gene Biotherapeutics, Inc. | - USD | -Infinity% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 101.844% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Evolutionary Genomics, Inc. | -1.02 Million USD | 141.382% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 105.96% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 263.209% |
| Innovation1 Biotech Inc. | -52.69 Thousand USD | 902.14% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 115.119% |
| Molecular Templates, Inc. | 50.39 Million USD | 99.161% |
| Navidea Biopharmaceuticals, Inc. | -119.29 Thousand USD | 454.342% |
| NexImmune, Inc. | -1.02 Million USD | 141.241% |
| Orgenesis Inc. | -5.72 Million USD | 107.384% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 101.648% |
| Point of Care Nano-Technology, Inc. | -4601.00 USD | 9287.394% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | 98.562% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 186.566% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 282.203% |
| Trevena, Inc. | 1.45 Million USD | 70.948% |
| Vaxxinity, Inc. | -2.23 Million USD | 118.922% |
| Vaccinex, Inc. | -16 Million USD | 102.641% |
| Vicapsys Life Sciences, Inc. | - USD | -Infinity% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 185.917% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -3540.93% |